The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Growth modulation index (GMI) as a metric of clinical benefit assessment among advanced soft tissue sarcoma (ASTS) patients receiving trabectedin as salvage therapy.
Nicolas Penel
Research Funding - PharmaMar
George D. Demetri
Consultant or Advisory Role - Amgen; ARIAD; ArQule; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Infinity; Johnson & Johnson; Merck; Novartis; Pfizer; Roche/Genentech; Sanofi ; ZIOPHARM Oncology
Research Funding - Amgen; ARIAD; ArQule; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Infinity; Johnson & Johnson; Merck; Novartis; Pfizer; Roche/Genentech; Sanofi ; ZIOPHARM Oncology
Jean-Yves Blay
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche
Honoraria - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche
Research Funding - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche
Sophie Cousin
No relevant relationships to disclose
Robert G. Maki
Research Funding - PharmaMar
Other Remuneration - PharmaMar
Sant P. Chawla
Honoraria - Cytotech; Cytrex; GlaxoSmithKline; Johnson & Johnson; Merck; Sanofi ; Threshold
Research Funding - Cytotech; Cytrex; GlaxoSmithKline; Johnson & Johnson; Merck; Sanofi ; Threshold
Other Remuneration - Cytotech; Cytrex; GlaxoSmithKline; Johnson & Johnson; Merck; Sanofi ; Threshold
Ian Robert Judson
Consultant or Advisory Role - PharmaMar (U)
Honoraria - PharmaMar
Research Funding - PharmaMar
Margaret von Mehren
Consultant or Advisory Role - Johnson & Johnson; PharmaMar
Patrick Schoffski
No relevant relationships to disclose
Jaap Verweij
No relevant relationships to disclose
Paolo Giovanni Casali
No relevant relationships to disclose
Sjoerd Rodenhuis
No relevant relationships to disclose
Javier Gomez
Employment or Leadership Position - PharmaMar
Stock Ownership - Zeltia
Antonio Nieto
Employment or Leadership Position - PharmaMar
Stock Ownership - Zeltia
Patrik Zintl
Employment or Leadership Position - PharmaMar
Stock Ownership - Zeltia
Maria Jose Pontes Valero
Employment or Leadership Position - PharmaMar
Stock Ownership - PharmaMar
Alexia Cassar
Employment or Leadership Position - PharmaMar
Axel Le Cesne
No relevant relationships to disclose